Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis
2021 · European Journal of Cancer · 54 citations
https://doi.org/10.1016/j.ejca.2021.03.040
D
Dominik A. Barth
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
48
Papers
867
Citations
18
h-index
24
i10-index
Dominik A. Barth is an academic researcher from Medical University of Graz. The author has contributed to research in topics: Cancer-related molecular mechanisms research & Inflammatory Biomarkers in Disease Prognosis & Cancer Immunotherapy and Biomarkers. The author has an h-index of 18, co-authored 41 publications.
ORCID: 0000-0003-0812-3024Papers by this author
worksA chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma
2023 · Frontiers in Immunology · 23 citations
https://doi.org/10.3389/fimmu.2023.1095195
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score Analysis
2022 · Clinical Genitourinary Cancer · 14 citations
https://doi.org/10.1016/j.clgc.2022.03.010
Real-world Evidence for Enfortumab Vedotin in Patients with Metastatic Urothelial Cancer: An Austrian Multicentre Study
2024 · Clinical Genitourinary Cancer · 6 citations
https://doi.org/10.1016/j.clgc.2024.102278
Preoperative fibrinogen/CRP score predicts survival in upper urothelial tract carcinoma patients undergoing radical curative surgery
2023 · World Journal of Urology · 4 citations
https://doi.org/10.1007/s00345-023-04379-y
Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study
2019 · Clinical & Translational Oncology · 3 citations
https://doi.org/10.1007/s12094-019-02037-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat